Grossardt, Christian <br/><br/>
Granulocyte-macrophage colony-stimulating factor-armed oncolytic measles virus is an effective therapeutic cancer vaccine.  [electronic resource] 

 -  Human gene therapy  Jul 2013 
 - 644-54 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1557-7422 
<br/><br/><label>Standard No.: </label>10.1089/hum.2012.205  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adaptive Immunity--immunology<br/>Adenocarcinoma--genetics<br/>Analysis of Variance<br/>Animals<br/>Chlorocebus aethiops<br/>Colonic Neoplasms--genetics<br/>Enzyme-Linked Immunospot Assay<br/>Genetic Engineering--methods<br/>Granulocyte-Macrophage Colony-Stimulating Factor--genetics<br/>Immunohistochemistry<br/>L-Lactate Dehydrogenase--metabolism<br/>Measles virus--genetics<br/>Mice<br/>Oncolytic Virotherapy--methods<br/>Oncolytic Viruses--genetics<br/>Vero Cells